Two small, debt-free Indian companies produce pharmaceutical-grade gelatin. Their margins have jumped, their balance sheets are clean, and they still trade in single-digit to mid-teens earnings multiples. Here is what the numbers actually say, and where the easy story falls apart.
Why This Pharmaceutical Supply Moat is Protected from China
A closer look in the specialty chemicals aisle of the Indian market and you will hear the same worry on repeat. Chinese factories keep dumping fluorochemicals and agrochemicals at prices local firms cannot match. Margins get squeezed, order books turn jumpy, and the China headache refuses to go away. So, some investors have started hunting for corners of the chemical world that China cannot easily flood. One such corner is hiding in plain sight.
Crushed bones, lime, acid and clean water go in. Out comes gelatin and ossein, the raw material behind pharmaceutical capsules, food gelling agents and protein supplements. It sounds unglamorous because it is. But it is also tightly regulated. A gelatin plant that wants to supply drug makers needs years of certification, audits and approvals. You cannot set one up in a weekend. That paperwork is the moat (a barrier that keeps new rivals out), and it is why a handful of Indian firms have the field largely to themselves.
Two of them are listed and small, with no famous investors on its share register. So, this is not a story about whose portfolio they sit in. It is a structural story about pricing power, clean balance sheets and valuations that still look cheap next to the wider chemical pack. Let us dig deeper, and let us also be honest about where the easy headline breaks down.
Incorporated in 1975 and based in Kochi, Nitta Gelatin India is the country’s largest maker of gelatin, ossein and collagen peptide. It is a joint venture with the Kerala State Industrial Development Corporation holding about 32% and Osaka-based Nitta Gelatin Inc of Japan holds about 43%, which together give the promoters a 75% grip.
With a market cap of Rs 1,562 cr, the company manufactures gelatin for pharma and food, di-calcium phosphate for poultry feed, and a consumer collagen range sold under the Wellnex brand.
Decoding the 75% Promoter Grip and the Regulatory Paperwork Moat
We must use the word monopoly a bit carefully here. Nitta is the biggest, but it is not alone. India Gelatine and Chemicals, Narmada Gelatines and a few others share the same small pond. What they all enjoy is a protected pocket. Gelatin for drug capsules must clear strict bio-chemical approvals, and the supply of clean animal bone is itself limited.
